• No results found

Hiv-1 Protease

Construction of a Human Immunodeficiency Virus Type 1 (HIV-1) Library Containing Random Combinations of Amino Acid Substitutions in the HIV-1 Protease due to Resistance by Protease Inhibitors

Construction of a Human Immunodeficiency Virus Type 1 (HIV-1) Library Containing Random Combinations of Amino Acid Substitutions in the HIV-1 Protease due to Resistance by Protease Inhibitors

... type 1 (HIV-1) protease. The HIV-1 protease contains 99 amino acids and functions in a dimeric form for processing of the Gag and Gag-Pol polyproteins during viral ...

7

Design and synthesis of inhibitors for the HIV 1 protease

Design and synthesis of inhibitors for the HIV 1 protease

... Although these cyclic alcohols did not possess the desired sp^ geometry at Pi and P^. (see Figure 2.15) they provided useful leads. Reduction of the double bonds was attempted using hydrogen gas over a palladium/ carbon ...

161

HIV-1 Protease-Substrate Coevolution in Nelfinavir Resistance

HIV-1 Protease-Substrate Coevolution in Nelfinavir Resistance

... type 1 (HIV-1) protease inhibitors (PIs) challenges the effectiveness of therapies in treating HIV-1-infected individuals and AIDS ...the protease (PR) that render the PIs ...

10

Docking Studies of HIV 1 Protease with Phytochemicals from Mappia foetida

Docking Studies of HIV 1 Protease with Phytochemicals from Mappia foetida

... When HIV enters the human body, its target is a subset of immune cells that contain CD4 ...effective HIV PR, HIV remains uninfectious because its work in HIV is to create mature protein ...

7

HIV-1 Protease, Reverse Transcriptase, and Integrase Variation

HIV-1 Protease, Reverse Transcriptase, and Integrase Variation

... HIV-1 protease (PR), reverse transcriptase (RT), and integrase (IN) variability presents a challenge to laboratories performing genotypic resistance ...low-abundance HIV-1 ...

13

Molecular Docking Studies; Dietary Compounds As HIV 1 Protease Inhibitors

Molecular Docking Studies; Dietary Compounds As HIV 1 Protease Inhibitors

... the protease and block its function, thereby suppressing the virus, which cannot transform to its mature, infectious ...form. HIV 1 Protease inhibitors are one class of drugs that target the ...

16

Multi step inhibition explains HIV 1 protease inhibitor pharmacodynamics and resistance

Multi step inhibition explains HIV 1 protease inhibitor pharmacodynamics and resistance

... the protease gene achieve their overall resistance pheno- type by altering both the entry and postentry dose-response ...of HIV-1 Env. MLV-E requires cleavage of its short CT by HIV-1 ...

14

Effects of HIV-1 protease on cellular functions and their potential applications in antiretroviral therapy

Effects of HIV-1 protease on cellular functions and their potential applications in antiretroviral therapy

... Type 1 (HIV-1) protease inhibitors (PIs) are the most potent class of drugs in antiretroviral ...resistant HIV-1 strains that are resistant to many or all current ...study ...

8

HIV-1 Protease Evolvability Is Affected by Synonymous Nucleotide Recoding

HIV-1 Protease Evolvability Is Affected by Synonymous Nucleotide Recoding

... the HIV-1 HXB2 strain ...MAX HIV-1 protease was generated by PCR amplification with a combination of three overlapping synthetic DNA oligonucleotides, as previously described ...MAX ...

11

Defining the level of human immunodeficiency virus type 1 (HIV-1) protease activity required for HIV-1 particle maturation and infectivity.

Defining the level of human immunodeficiency virus type 1 (HIV-1) protease activity required for HIV-1 particle maturation and infectivity.

... 99-amino-acid protease. No protease expression was ob- served when this gene was cloned into the pTacTac vector (data not ...the protease and a highly expressed ...the protease gene to that of ...

8

HIV 1 protease induced apoptosis

HIV 1 protease induced apoptosis

... of HIV-1 PR on selected anti- and pro-apoptotic Bcl-2 family proteins involved in mito- chondrial outer membrane permeabilization (MOMP) using: (i) in vivo cleavage of cellular proteins in HeLa or HEK-293 ...

15

Human immunodeficiency virus type 1 (HIV-1) protein Vif inhibits the activity of HIV-1 protease in bacteria and in vitro.

Human immunodeficiency virus type 1 (HIV-1) protein Vif inhibits the activity of HIV-1 protease in bacteria and in vitro.

... for 1 h, and washed, and cell pellets were lysed directly in Laemmli sample buffer containing 4% sodium dodecyl sulfate ...visualize HIV-1-specific proteins; bound antibody was detected by ...

8

HIV 1 protease inhibitor mutations affect the development of HIV 1 resistance to the maturation inhibitor bevirimat

HIV 1 protease inhibitor mutations affect the development of HIV 1 resistance to the maturation inhibitor bevirimat

... three protease backgrounds (HXB2, PR-1 and ...gag- protease recombinant HIV-1 samples to select for bevir- imat ...mutated protease, which is in line with our previous in vivo ...

12

Generation and characterization of a human immunodeficiency virus type 1 (HIV-1) mutant resistant to an HIV-1 protease inhibitor.

Generation and characterization of a human immunodeficiency virus type 1 (HIV-1) mutant resistant to an HIV-1 protease inhibitor.

... Viruses obtained from treated and untreated cultures were called the escape and passaged viruses, respectively, and were used to infect MOLT-4 cells to establish chronically infected pro[r] ...

7

HIV 1 protease cleaves the serine threonine kinases RIPK1 and RIPK2

HIV 1 protease cleaves the serine threonine kinases RIPK1 and RIPK2

... fied HIV-1 PR can cleave RIPK1 and RIPK2 in various cell types, we next asked whether RIPK1 and RIPK2 are cleaved during HIV-1 ...dotyped HIV-1 ...

16

The L76V mutation in HIV-1 protease is potentially associated with hypersusceptibility to protease inhibitors Atazanavir and Saquinavir: is there a clinical advantage?

The L76V mutation in HIV-1 protease is potentially associated with hypersusceptibility to protease inhibitors Atazanavir and Saquinavir: is there a clinical advantage?

... Figure 1 Resensitizing effects of the L76V mutation are visible in phenotype results: Phenotypic resistance analysis before and after manifestation of L76V in two representative patients ...

9

Intracellular expression of human immunodeficiency virus type 1 (HIV-1) protease variants inhibits replication of wild-type and protease inhibitor-resistant HIV-1 strains in human T-cell lines.

Intracellular expression of human immunodeficiency virus type 1 (HIV-1) protease variants inhibits replication of wild-type and protease inhibitor-resistant HIV-1 strains in human T-cell lines.

... our HIV-1 challenge assays, these differences were not readily ...intermediate-dose HIV-1 HXB3 and NF6 infection experiments, both td PR variants D25N and KWW showed comparable anti-HIV ...

8

Optimizing HIV-1 protease production in Escherichia coli as fusion protein

Optimizing HIV-1 protease production in Escherichia coli as fusion protein

... mature HIV-1Pr was designed by in silico back translation of the amino acid sequence reported in the database (GenBank Accession ...file 1, Figure S1) ...

10

Virological Response to Highly Active Antiretroviral Therapy in Patients Infected with Human Immunodeficiency Virus Type 2 (HIV 2) and in Patients Dually Infected with HIV 1 and HIV 2 in The Gambia and Emergence of Drug Resistant Variants

Virological Response to Highly Active Antiretroviral Therapy in Patients Infected with Human Immunodeficiency Virus Type 2 (HIV 2) and in Patients Dually Infected with HIV 1 and HIV 2 in The Gambia and Emergence of Drug Resistant Variants

... analysis. HIV-2 RNA was extracted from 140 ␮l of EDTA-plasma using the QIAamp viral RNA kit (Qiagen, Venlo, The Netherlands) and was eluted into 50 ␮l nuclease-free ...entire HIV-2 protease and RT ...

9

BioAfrica's HIV 1 Proteomics Resource: Combining protein data with bioinformatics tools

BioAfrica's HIV 1 Proteomics Resource: Combining protein data with bioinformatics tools

... [15], PROSITE [16] or ProDom [17]; perform similarity searches using the BLAST program available at Genbank [18], conduct structural comparisons using the BioAfrica BLAST Structure program; determine amino acid compo- ...

14

Show all 10000 documents...

Related subjects